Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
410 JPY | +0.24% | -12.77% | -29.07% |
May. 09 | StemRIM to Seek Shareholders' Approval on Capital Stock Reduction | MT |
Mar. 13 | StemRIM Announces Initiation of Phase 2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.07% | 160M | |
-1.62% | 91.26B | |
-2.63% | 38.17B | |
-12.76% | 32.85B | |
+66.54% | 26.74B | |
-13.02% | 15.93B | |
-5.27% | 13.37B | |
-10.50% | 11.77B | |
-49.11% | 10.27B | |
+187.82% | 10.92B |
- Stock Market
- Equities
- 4599 Stock
- News StemRIM
- StemRIM(TSE: 4599) added to S&P Global BMI Index